Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 2 (IL-2) is a cytokine and key immunoregulatory protein with significant roles in immune system function, particularly in T cell biology and cancer immunotherapy. It stimulates the growth, proliferation, and differentiation of T lymphocytes, B lymphocytes, and NK cells. IL-2 plays a dual role: it can have both immunostimulatory effects—enhancing immune responses—and immunoinhibitory effects—supporting regulatory mechanisms to prevent autoimmunity or excessive inflammation depending on context and target cell type.
Stimulates the growth, proliferation, and differentiation of T lymphocytes, B lymphocytes, and NK cells by binding to the IL-2 receptor and activating intracellular signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 2 (IL-2).